BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
Number Cited Articles
1
Ponnuraj Nagendraprabhu, Ganapasam Sudhandiran. Astaxanthin inhibits tumor invasion by decreasing extracellular matrix production and induces apoptosis in experimental rat colon carcinogenesis by modulating the expressions of ERK-2, NFkB and COX-2Investigational New Drugs 2011; 29(2): 207 doi: 10.1007/s10637-009-9342-5
2
Eun Jung Ahn, Soon Sup Chung, Ryung-Ah Lee, Kwang-Ho Kim. The Expression and Clinical Correlations of Matrix Metalloproteinase-2, -7, -9, and -12 in Colorectal CancerJournal of the Korean Society of Coloproctology 2009; 25(1): 26 doi: 10.3393/jksc.2009.25.1.26
3
Kyung Sook Park, Seon Jeong Kim, Kyung Ho Kim, Jin Cheon Kim. Clinical characteristics of TIMP2, MMP2, and MMP9 gene polymorphisms in colorectal cancerJournal of Gastroenterology and Hepatology 2011; 26(2): 391 doi: 10.1111/j.1440-1746.2010.06504.x
4
Gao-Chao Fan, Li Han, Hua Zhu, Jian-Rong Zhang, Jun-Jie Zhu. Ultrasensitive Photoelectrochemical Immunoassay for Matrix Metalloproteinase-2 Detection Based on CdS:Mn/CdTe Cosensitized TiO2 Nanotubes and Signal Amplification of SiO2@Ab2 ConjugatesAnalytical Chemistry 2014; 86(24): 12398 doi: 10.1021/ac504027d
5
Marwan Emara, Po-Yin Cheung, Krzysztof Grabowski, Grzegorz Sawicki, Mietek Wozniak. Serum levels of matrix metalloproteinase-2 and -9 and conventional tumor markers (CEA and CA 19-9) in patients with colorectal and gastric cancersClinical Chemistry and Laboratory Medicine 2009; 47(8) doi: 10.1515/CCLM.2009.212
6
Magdalena Groblewska, Barbara Mroczko, Mariusz Gryko, Bogusław Kędra, Maciej Szmitkowski. Matrix metalloproteinase 2 and tissue inhibitor of matrix metalloproteinases 2 in the diagnosis of colorectal adenoma and cancer patients.Folia Histochemica et Cytobiologica 2011; 48(4) doi: 10.2478/v10042-010-0076-1
7
Xin Zhao, Xia Feng, Cun Wang, Deguang Peng, Kai Zhu, Jia-Le Song. Anticancer activity of Nelumbo nucifera stamen extract in human colon cancer HCT-116 cells in vitroOncology Letters 2017; 13(3): 1470 doi: 10.3892/ol.2016.5547
8
Tae-Dong Kim, Kyoung-Sub Song, Ge Li, Hoon Choi, Hae-Duck Park, Kyu Lim, Byung-Doo Hwang, Wan-Hee Yoon. Activity and expression of urokinase-type plasminogen activator and matrix metalloproteinases in human colorectal cancerBMC Cancer 2006; 6(1) doi: 10.1186/1471-2407-6-211
9
Stefaan Mulier, Yicheng Ni, Jacques Jamart, Luc Michel, Guy Marchal, Theo Ruers. Radiofrequency Ablation Versus Resection for Resectable Colorectal Liver Metastases: Time for a Randomized Trial?Annals of Surgical Oncology 2008; 15(1): 144 doi: 10.1245/s10434-007-9478-5
10
Thais Peretti, Jaques Waisberg, Ana Maria A. A. Mader, Leandro L. de Matos, Ricardo B. da Costa, Gleice Margarete de S. Conceição, Antônio Carlos Lopes, Helena B. Nader, Maria Aparecida S. Pinhal. Heparanase-2, syndecan-1, and extracellular matrix remodeling in colorectal carcinomaEuropean Journal of Gastroenterology & Hepatology 2008; 20(8): 756 doi: 10.1097/MEG.0b013e3282fc2649
11
Thao Phuong Bui, Anh Ngoc Hoang, Phuong Lan Le, Bich Thi Pham, Linh Thi Tu Nguyen, Ha Minh Do, To Van Ta, Thai Hong Trinh. Matrix metalloproteinases in Vietnamese patients with colorectal cancerOncology Letters 2017; 13(4): 2097 doi: 10.3892/ol.2017.5680
12
O. Schwandner, A. Schlamp, R. Broll, H. P. Bruch. Clinicopathologic and prognostic significance of matrix metalloproteinases in rectal cancerInternational Journal of Colorectal Disease 2006; 22(2): 127 doi: 10.1007/s00384-006-0173-y
13
Z. Cavdar, A. E. Canda, C. Terzi, S. Sarioglu, M. Fuzun, G. Oktay. Role of gelatinases (matrix metalloproteinases 2 and 9), vascular endothelial growth factor and endostatin on clinicopathological behaviour of rectal cancerColorectal Disease 2011; 13(2): 154 doi: 10.1111/j.1463-1318.2009.02105.x
14
Xian Xiao, Xiaofang Sun, Pengwen Ni, Yao Huang, Ting Xie. Phosphaturic mesenchymal tumor and related wound problemMedicine 2018; 97(40): e12507 doi: 10.1097/MD.0000000000012507
15
Lars Frich, Kristin Bjørnland, Solveig Pettersen, Ole Petter F. Clausen, Ivar P. Gladhaug. Increased Activity of Matrix Metalloproteinase 2 and 9 After Hepatic Radiofrequency AblationJournal of Surgical Research 2006; 135(2): 297 doi: 10.1016/j.jss.2006.05.010
16
Moo-Jun Baek. Prognostic Role of MMPs in Colorectal CancerJournal of the Korean Society of Coloproctology 2011; 27(3): 105 doi: 10.3393/jksc.2011.27.3.105
17
Charles E Patek, Mark J Arends, Lorraine Rose, Feijun Luo, Marion Walker, Paul S Devenney, Rachel L Berry, Nicola J Lawrence, Rachel A Ridgway, Owen J Sansom, Martin L Hooper. The pro-apoptotic K-Ras 4A proto-oncoprotein does not affect tumorigenesis in the Apc Min/+mouse small intestineBMC Gastroenterology 2008; 8(1) doi: 10.1186/1471-230X-8-24
18
Min Zhang, Yanyan Liu, Hailiang Feng, Xiaocui Bian, Wenjing Zhao, Zhenli Yang, Bei Gu, Zhanwen Li, Yuqin Liu. CD133 Affects the Invasive Ability of HCT116 Cells by Regulating TIMP-2The American Journal of Pathology 2013; 182(2): 565 doi: 10.1016/j.ajpath.2012.10.015
19
Xing-Xiang He, Ken Chen, Jun Yang, Xiao-Yu Li, Huo-Ye Gan, Cheng-Yong Liu, Thomas R. Coleman, Yousef Al-Abed. Macrophage Migration Inhibitory Factor Promotes Colorectal CancerMolecular Medicine 2009; 15(1-2): 1 doi: 10.2119/molmed.2008.00107
20
Dipshikha Bajracharya, Bijayatha Shrestha, Asha Kamath, Aparna Menon, Raghu Radhakrishnan. Immunohistochemical Correlation of Matrix Metalloproteinase-2 and Tissue Inhibitors of Metalloproteinase-2 in Tobacco Associated Epithelial DysplasiaDisease Markers 2014; 2014: 1 doi: 10.1155/2014/197813
21
Magdalena Groblewska, Barbara Mroczko, Mariusz Gryko, Anna Pryczynicz, Katarzyna Guzińska-Ustymowicz, Bogusław Kędra, Andrzej Kemona, Maciej Szmitkowski. Serum levels and tissue expression of matrix metalloproteinase 2 (MMP-2) and tissue inhibitor of metalloproteinases 2 (TIMP-2) in colorectal cancer patientsTumor Biology 2014; 35(4): 3793 doi: 10.1007/s13277-013-1502-8
22
A. Pryczynicz, M. Gryko, V. Dymicka-Piekarska, Ł Lewczuk, A. Wakulewska, M. Ozimkiewicz, A. Lebelt, K. Guzińska-Ustymowicz. Clinical usefulness of MMP-2 and TIMP-2 concentrations in the preoperative serum of patients with colorectal cancerProgress in Health Sciences 2016; 6(1): 32 doi: 10.5604/01.3001.0009.5107
23
Marta Łukaszewicz-Zając, Barbara Mroczko, Maciej Szmitkowski. Gastric cancer — The role of matrix metalloproteinases in tumor progressionClinica Chimica Acta 2011; 412(19-20): 1725 doi: 10.1016/j.cca.2011.06.003
24
Hilal Gungor, Nevin Ilhan, Hatice Eroksuz. The effectiveness of cyclooxygenase-2 inhibitors and evaluation of angiogenesis in the model of experimental colorectal cancerBiomedicine & Pharmacotherapy 2018; 102: 221 doi: 10.1016/j.biopha.2018.03.066